3hon MSN
I Tried Daxxify, the Neurotoxin That Promises to Kick in Faster and Last Longer—Here Are My Thoughts
A newer neuromodulator claims faster results and longer wear than its counterparts. Here’s what happened when I tried it.
The lab, led by Carleara Weiss, explores the relationship between Alzheimer’s disease and biomarkers of neurodegeneration, ...
Mississippi vape shops are rushing to sell non-FDA-approved vapes and cigarettes before a statewide ban takes effect next ...
Compounded GLP-1 medications bypass FDA safety reviews, leading to over 1,000 reported adverse events and double the hospitalization rates of approved versions.
Discover why Rigel Pharma (RIGL) is a contrarian biotech BUY with surging revenues, strong drug sales, and 20-30% upside ...
The FDA approved an intrathecal form of Novartis’ spinal muscular atrophy gene therapy Zolgensma on Monday, broadening access ...
Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated ...
Sex, Drugs and Who Has Control,' explores the fight to bring Addyi, a pill that helps increase women's sexual pleasure, to ...
MedPage Today on MSN
FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease
The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...
Good Housekeeping on MSN
Is It Safe to Microdose GLP-1s? Here's What Doctors Want You to Know
Bravo TV host Andy Cohen told the TODAY show that microdosing a GLP-1 drug helped him lose “a good chunk of weight.” The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback